The Indian Institute of Chemical Technology (IICT) has collaborated with LAXAI Life Sciences to produce Active Pharmaceutical Ingredients inside India.
This will help to reduce dependence of pharmaceutical sector on Chinese imports.
The Active Pharmaceutical Ingredients are also known as bulk drugs.
They are the main part of the drugs that produce intended effects.
India is the third largest producer of API in the world.
Around two-third of the API of India are imported from China.
In March 2020, the Government of India had constituted a committee under chairmanship of CDSCO (Central Drugs Standard Control Organization) director to revive the API industry.